New hope for aggressive uterine cancer: drug combo trial launches
NCT ID NCT06795009
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 23 times
Summary
This study tests a new drug, zanzalintinib, combined with standard chemotherapy (paclitaxel) in people with recurrent high-grade uterine cancer. The goal is to find the safest and most effective dose and see if the combination can shrink tumors. About 36 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
NOT_YET_RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-••••
Contact
-
University of New Mexico
NOT_YET_RECRUITINGAlbuquerque, New Mexico, 87106, United States
Contact Phone: •••-•••-••••
Contact
-
University of Oklahoma
NOT_YET_RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-••••
Contact
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.